These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3776149)

  • 41. [The significance of autoimmune reactions in the treatment of erysipelas].
    Frolov VM; Peresadin NA; Baskakov IN; Trofimenko AN; Starik AD
    Vrach Delo; 1988 Sep; (9):107-10. PubMed ID: 3212978
    [No Abstract]   [Full Text] [Related]  

  • 42. [Erysipelas: epidemiologic, clinical and therapeutic data].
    Jeune R
    Ann Dermatol Venereol; 1991; 118(8):545-6. PubMed ID: 1952693
    [No Abstract]   [Full Text] [Related]  

  • 43. [Complex treatment of patients with complicated forms of erysipelas].
    Korolev MP; Spesivtsev IuA; Tolstov OA; Bechvaia LD; Chulikov OV
    Vestn Khir Im I I Grek; 2000; 159(4):64-9. PubMed ID: 11011408
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pristinamycin in the treatment of acute bacterial dermohypodermitis in adults. An open study of 42 patients].
    Bernard P; Risse L; Bonnetblanc JM
    Ann Dermatol Venereol; 1996; 123(1):16-20. PubMed ID: 8734110
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Current methods of treating patients with erysipelas].
    Cherkasov VL
    Klin Med (Mosk); 1972 Mar; 50(3):132-6. PubMed ID: 5024817
    [No Abstract]   [Full Text] [Related]  

  • 46. [Histologic studies on the skin of patients with recurrent erysipelas].
    Schneider I; Czakó F
    Dermatol Monatsschr; 1972 Mar; 158(3):173-80. PubMed ID: 5032919
    [No Abstract]   [Full Text] [Related]  

  • 47. [Dynamics of erythrocyte electrophoretic mobility in patients with various forms of erysipelas].
    Erovichenkov AA; Sadovskaia GV; Pak SG; Kozinets GI; Popova OV
    Ter Arkh; 2001; 73(11):73-5. PubMed ID: 11806213
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hospitalization criteria for erysipelas: prospective study in 145 cases].
    Jégou J; Hansmann Y; Chalot F; Roger M; Faivre B; Granel F; Scrivener Y; Cairey-Remonnay S; Bernard P
    Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 1):375-9. PubMed ID: 12055535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prevention of severe forms of elephantiasis of the limbs].
    Savchenko TV; Grishina IA
    Sov Med; 1976 Mar; (3):104-7. PubMed ID: 968556
    [No Abstract]   [Full Text] [Related]  

  • 50. [Experience with the clinical use of methyluracil, sodium nucleinate and levamisole in the complex treatment of erysipelas].
    Frolov VM; Rychnev VE; Peresadin NA
    Vrach Delo; 1983 Oct; (10):102-6. PubMed ID: 6359683
    [No Abstract]   [Full Text] [Related]  

  • 51. Erysipelas after breast cancer treatment.
    Naveen KN; Pai VV; Sori T; Kalabhavi S
    Breast; 2012 Apr; 21(2):218-9. PubMed ID: 21925882
    [No Abstract]   [Full Text] [Related]  

  • 52. [Chemotherapy effectiveness in chronic and hyperchronic forms of destructive pulmonary tuberculosis].
    Kartoziia LS
    Probl Tuberk; 1981 Apr; (4):32-5. PubMed ID: 7255373
    [No Abstract]   [Full Text] [Related]  

  • 53. [Long-term preventive use of sulfamerazine in chronic recurrent erysipelas].
    Härtel S; Gramatté T; Scholz A; Terhaag B
    Dermatol Monatsschr; 1988; 174(8):485-92. PubMed ID: 3139469
    [No Abstract]   [Full Text] [Related]  

  • 54. [Agranulocytosis in patients with erysipelas].
    Cherkasov VL
    Sov Med; 1973 Apr; 36(4):138-9. PubMed ID: 4769997
    [No Abstract]   [Full Text] [Related]  

  • 55. [The hemodynamic disorders in erysipelas of the lower extremities].
    Bondarov LS; Zhidkikh VN
    Ter Arkh; 1993; 65(11):55-7. PubMed ID: 8108800
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Predisposing and triggering factors in erysipelas].
    Santos I; Andrade Lima MB; Andrade Lima BP
    Med Cutan Ibero Lat Am; 1984; 12(5):399-402. PubMed ID: 6396465
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recurrence of lymphoedema-associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study.
    Vignes S; Dupuy A
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):818-22. PubMed ID: 16898904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Erysipelas and elephantiasis of the scrotum. Surgical and drug therapy].
    Geyer H; Geyer A; Schubert J
    Urologe A; 1995 Jan; 34(1):59-61. PubMed ID: 7879325
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Endolymphatic antibiotic therapy of erysipelas].
    Ermolov AS; Udovskiĭ EE; Grigorian AR
    Khirurgiia (Mosk); 1985 Jun; (6):120-2. PubMed ID: 4046364
    [No Abstract]   [Full Text] [Related]  

  • 60. Blistering erysipelas: not a rare entity.
    Chong FY; Thirumoorthy T
    Singapore Med J; 2008 Oct; 49(10):809-13. PubMed ID: 18946616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.